請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26417
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳信志 | |
dc.contributor.author | Cheng-Yu Wu | en |
dc.contributor.author | 鄔承祐 | zh_TW |
dc.date.accessioned | 2021-06-08T07:09:31Z | - |
dc.date.copyright | 2008-08-04 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-08-01 | |
dc.identifier.citation | 陳國群。1997。最新糖尿病精要。藝軒圖書出版社。台北市。
Abraham, E. J., C. A. Leech, J. C. Lin, H. Zulewski and J. F. Habener. 2002. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 143: 3152-3161. Baharvand, H., H. Jafary, M. Massumi and S. K. Ashtiani. 2006. Generation of insulin-secreting cells from human embryonic stem cells. Dev. Growth Differ. 48: 323-32. Barry F. P. 2003. Biology and clinical applications of mesenchymal stem cells. Birth Defects Res. 69: 250-256. Bernard, B. A. 2008. Human skin stem cells. J. Soc. Biol. 202: 3-6. Berry L., M. E. Grant, and J. McClure. 1992. Bone marrow-derived chondrogenesis in vitro. J. Cell. Sci. 101: 333-342. Blotard, C., M. C. Villa, C. Becourt, H. P. Gia, C. Huc, P. Sempe, M. M. Protier. 1992. Peripherin: An islet antigen that is cross-reactive with nonobese diabetic mouse class 11 gene products. Proc. Natl. Acad. Sci. 89:172-6. Bock, T. 2004. The source(s) for new pancreatic beta cells in adult life. Bioessays. 26: 1156-9. Bonner-Weir, S., D. Deery, I. J. Leahy, G. C. Weir. 1989. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38: 49–53. Bonner-Weir, S., A. Inada, S. Yatoh, W. C. Li, T. Aye, E. Toschi, A. Sharma. 2008. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem. Soc. Trans. 36: 353-6. Bunnell, B. A., B. T. Estes, F. Guilak, J. M. Gimble. 2008. Differentiation of adipose stem cells. Methods Mol. Biol. 456:155-71. Brendel, M.D., B. J. Hering, A. O. Schultz, R. G. Bretzel. 2001. International Islet Transplant Registry, Newsletter 9, Vol 8. Bretzel, R. G., M. Eckhard, H. Jahr and M. D. Brendel. 2006. Islet transplantation, stem cell transfer and regenerative therapy in diabetes mellitus. Dtsch. Med. Wochenschr. 131: 903-6. Bretzel, R.G., H. Jahr, M. Eckhard, I. Martin, D. Winter and M.D. Brendel. 2007. Islet cell transplantation today. Langenbecks Arch. Surg. 392: 239-53. Calne, R. 2005. Cell transplantation for diabetes. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360: 1769-74. Chan, J., W. Clements, J. Field, Z. Nasa, P. Lock, F. Yap, B. H. Toh and F. Alderuccio. 2006. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. J. Gene. Med. 8: 1281-90. Chang, E. N., C. H. Scudamore and S. W. Chung. 2004. Transplantation: focus on kidney, liver and islet cells. Can. J. Surg. 47: 122-9. Chang, F. C., K. H. Hsu , S. H. Chiou , Low-Tone Ho L.,Yu-Show F., Shih-Chieh H. 2007. Fibronectin and pellet suspension culture promote differentiation of human mesenchymal stem cells into insulin producing cells. J. Biomed. Mater. Res. A. early view. Chao, K. C., K. F. Chao, Y. S. Fu and S. H. Liu. 2008. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS. ONE. 3: 1451. Chen, C., Y. Zhang, X. Sheng, C. Huang and Y. Q. Zang. 2008. Differentiation of embryonic stem cells towards pancreatic progenitor cells and their transplantation into streptozotocin-induced diabetic mice. Cell Biol. Int. 32: 456-61. Chen, L. B., X. B. Jiang and L. Yang. 2004. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J. Gastroenterol. 10: 3016-20. Choi, K. S., J. S. Shin, J. J. Lee, Y. S. Kim, S. B. Kim and C.W. Kim. 2005. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem. Biophys. Res. Commun. 330: 1299-305. Conget, P. A. and J. J. Minguell. 1999. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J. Cell. Phys. 181: 67-73. Dieterle, C., M. D. Brendel, J. Seissler, M. Eckhard, R.G. Bretzel, and R. Landgraf. 2006. Therapy of diabetes mellitus. Pancreas transplantation, islet transplantation, stem cell and gene therapy. Internist. (Berl). 47: 489-96, 498-501. Donald, F. S., M. D. Chicago. 1977. Insulin today. Diabetes. 26: 322-340. Docherty, K., A. S. Bernardo and L. Vallier. 2007. Embryonic stem cell therapy for diabetes mellitus. Semin. Cell Dev. Biol. 18: 827-38. Denker, H. W. 2008. Totipotency/Pluripotency and Patentability. 2008. Stem Cells. 10: 232 Dufrane, D., Steenberghe, M., Goebbels, R. M., Saliez, A., Guiot, Y., Gianello, P. 2003. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27: 3201-3208. Ende, N., R. Chen, A. S. Reddi. 2004. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem. Biophys. Res. Commun. 321: 168-71. Friedenstein, A., R. Chailakhyan, U. Gerasimov. 1987. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 20: 263-272 Gao, R., Ustinov J, Pulkkinen MA, Lundin K, Korsgren O, Otonkoski T. 2003. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 52: 2007-2015. Hess, D., L. Li, M. Martin, S. Sakano, D. Hill, B. Strutt, S. Thyssen, D. A. Gray, M. Bhatia. 2003. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21: 763–770. Ianus, A., G. G. Holz, N. D. Theise, M. A. Hussain. 2003. In vivo derivation of glucose competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin. Invest. 111: 843–850. Jiang, J., M. Au, K. Lu, A. Eshpeter, G. Korbutt, G. Fisk, A.S. Majumdar. 2007. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells. 25: 1940-53. Johnstone, B., T. M. Hering, A. I. Caplan. 1998. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell. Res. 238: 265-272. Karnieli, O., Y. Izhar-Prato, S. Bulvik, and S. Efrat. 2007. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells. 25: 2837-2844. Kaufman, D. L., C. Clare-Salzier, J. Tian, T. Forsthuber, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72. Kitamura, T., K. Kimura, D. T. Furuya, M. Suzuki, T. Yoshida, M. Saito. 2003. Proinsulin C-peptide increase nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of wistar rats. Diabetologia 46: 1698-1705. Kim, J. H., S. N. Park, H. Suh. 2007. Generation of insulin-producing human mesenchymal stem cells using recombinant adeno-associated virus. Yonsei. Med. J. 48: 109-19. Kojima H, Fujimiya M, Matsumura K, Nakahara T, Hara M, Chan L. 2004. Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc. Natl. Acad. Sci. U S A 101:2458–2463 Kodama, S., T. Toyonaga, T. Kondo, K. Matsumoto, K. Tsuruzoe, J. Kawashima, H. Goto, K. Kume, S. Kume, M. Sakakida, E. Araki. 2005. Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice. Biochem. Biophys. Res. Commun. 327: 1170-8. Kobayashi. Y., K. Naruse, Y. Hamada, E. Nakashima, K. Kato, N. Akiyama, H. Kamiya, A. Watarai, M. Nakae, Y. Oiso, J. Nakamura. 2005. Human Proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells in high-glucose condition. Diabetologia 48: 2396-2401. Korec, R. 2004. From Langerhans islets to pancreas transplantation over the past 30 years: a review with personal contributions. Cell Tissue Bank 5: 177-83. Kuwahara, R., A. V. Kofman, C. S Landis, E. S Swenson, E. Barendswaard, N. D. Theise. 2008. The hepatic stem cell niche: Identification by label-retaining cell assay. Hepatology 47(6): 1994-2002. Lambert, A. P., K. M. Gillespie, G..Thomson. 2004 Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89:4037–4043. Lechner, A. 2004. Stem cells and regenerative medicine for the treatment of type 1 diabetes: the challenges lying ahead. Pediatr. Diabetes. Suppl. 2: 88-93. Lee, D. D., E. Grossman, A. S. Chong. 2008. Cellular therapies for type 1 diabetes. Horm. Metab. Res. 40: 147-54. Lepich, T., R. Wilk, J. Dabek, A. Piwowarczyk, B. Kuczera, J.S. Gielecki. 2005. Transplantation of islets of langerhans--alternative or solution in type 1 diabetes treatment?. Wiad. Lek. 58: 437-41. Lacy, P., and M. Kostianovsky. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39. Liao, Y. H., C. B. Verchere, G. L. Warnock. 2007. Adult stem or progenitor cells in treatment for type 1 diabetes: current progress. Can. J. Surg. 50: 137-42. Lim, F., A. M. Sun. 1980. Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908-910. Li, Y., R. Zhang, H. Qiao, H. Zhang, Y. Wang, H. Yuan, Q. Liu, D. Liu, L. Chen, X. Pei. 2007. Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J. Cell Physiol. 211: 36-44. Majumdar, M. K., M. Keane-Moore, D. Buyaner, W. B. Hardy, M. A. Moorman, K. R. Mclntosh, J. D. Mosca. 2003. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 10: 228-241. Martin, D. R., N. R. Cox, T. L. Hathcock. 2002. Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp. Hematol. 30: 879-886. Mathis, D., L. Vence, C. Benoist. 2001. β-cell death during progression to diabetes. Nature 414: 792-798 McGuckin, C., M. Jurga, H. Ali, M. Strbad, N. Forraz. 2008. Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro. Nat. Protoc. 3(6): 1046-55. Mutskov V., Bruce M. Raaka, Gary Felsenfeld, Marvin C. Gershengorn. 2007. The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression. Stem Cells 25(12) :3223-33. Nagata, N., Y. Gu, H. Hori, A. N. Balamurugan, M. Touma ,Y. Kawakami, W. Wang, T. T. Baba, A. Satake, M. Nozawa, Y. Tabata, K. Inoue. 2001. Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix. Cell Transplant. 10 : 447-51 Narang, A. S., and R. I. Mahato. 2006. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev. 58: 194-243. Narushima, M., N. Kobayashi, T. Okitsu, Y. Tanaka, S. A. Li, Y. Chen, A. Miki, K. Tanaka, S. Nakaji, K. Takei, H. S. Jun, H. Noguchi, P. Leboulch, N. Tanaka , J. W. Yoon. 2005. Human β-cell line for transplantation therapy to control type 1 diabetes. Nat. Biotechnol. 23: 1274-1282. Noguchi, H., G. Xu, S. Matsumoto, H. Kaneto, N. Kobayashi, S. Bonner-Weir, S. Hayashi. 2006. Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant. 15: 929-38. Palma, C. A., R. Lindeman, B. E. Tuch. 2008. Blood into beta-cells: can adult stem cells be used as a therapy for Type 1 diabetes? Regen. Med. 3: 33-47. Pittenger, F., A. Mackay, S. Beck. 1999. Multilineage potential of adult human mesenchymal stem cells. Science. 284: 143-147. Pittenger, M. F., A. M. Mackay , S. C. Beck , R. K. Jaiswal, R. Douglas , J. D. Mosca , M. A. Moorman, D. W. Simonetti, D. R. Craig, S. Marshak. 1990. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-7. Porat, S., and Y. Dor. 2007. New sources of pancreatic beta cells. Curr. Diab. Rep. 7: 304-8. Pountos, I, and V. G. Peter. 2005. Biology of mesenchymal stem cells. Int. J. Care Injured. 36: 8-12. Ren, J., P. Jin, E. Wang, E. Liu, D. M. Harlan, X. Li, D. F. Stroncek. 2007. Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation. J. Transl. Med. 5: 1. Ringe, J., C. Kaps, B. Schmitt, K. Buseher, J. Bartel, H. Smolian, O. Schultz, G. R. Burmester, T. Haupl, M. Sittinger. 2002. Porcine mesenchymal stem cells induction of distinct mesenchymal cell lineages. Cell Tissue Res. 307: 321-327. Robertson, R. P. 2004. Islet Transplantation as a Treatment for Diabetes — A Work in Progress. N. Engl. J. Med. 350: 694-705 Roche, E., J. A. Reig, A. Campos, B. Paredes, J. R. Isaac, S. Lim, R. Y. Calne, B. Soria. 2005. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes. Transpl. Immunol. 15: 113-29. Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R., Shapiro, A. M. 2005. Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060-2069. Sarah, W., R. Sicree, G. Roglic, H. King, A. Green. 2004 Global Prevalence of Diabetes. Diabetes Care 27: 1047-1053. Segev, H., B. Fishman, A. Ziskind, M. Shulman, and J. Itskovitz-Eldor. 2004. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells. 22: 265-274. Shapiro, A. M., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., Rajotte, R.V. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343: 230-238 Sipione, S., A. Eshpeter, J.G. Lyon, G.S. Korbutt, and R.C. Bleackley. 2004. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia. 47: 499-508. Soria, B., E. Roche, G. Berna, L. Q. Trinidad, J. A. Reig, F. Martin. 2000. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49: 157-162. Soria, B. 2001. In-vitro differentiation of pancreatic beta-cells. Differentiation 68: 205–219 Stanley, E.G., and A.G. Elefanty. 2008. Building better beta cells. Cell Stem Cell. 2: 300-1. Stainier, D. 2006. No stem cell is an islet (yet). N. Engl. J. Med. 354: 521-523. Stanley, E. G., A. G. Elefanty. 2008. Building better beta cells. Cell Stem Cell 2: 300-301. Steptoe, R. J., J. M. Ritchie, L. K. Jones, L. C. Harrison. 2005. Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells. Diabetes. 54: 434-42. Street, C. N., R. V. Rajotte, G. S. Korbutt. 2003. Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes. Curr. Top. Dev. Biol. 58: 111-136. Stroncek, D., and E. J. Read. 2004. Cell processing: current status and future directions. Yonsei. Med. J. 45 Suppl: 1-4. Street, C. N., R. V. Rajotte, G. S. Korbutt. 2003. Stem cells: A promising source of pancreatic islets for transplantation in type 1 diabetes. Curr. Top. Dev. Biol. 58: 111-136. Stroncek, D., E. J. Read. 2004. Cell processing: Current status and future directions. Yonsei. Med. J. 45 Suppl.: 1-4. Sun, S., Z. Guo, X. Xiao, B. Liu, X. Liu, P. H. Tang, N. Mao. 2003. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cell. 21: 527-535. Tang, D. Q., L. Z. Cao, B. R. Burkhardt, C. Q. Xia, S. A. Litherland, M. A. Atkinson, and L. J. Yang. 2004. In Vivo and In Vitro Characterization of Insulin- Producing Cells Obtained From Murine Bone Marrow. Diabetes 53: 1721-1732. Taneera, J., A. Rosengren , E. Renstrom, J. M. Nygren, P. Serup, P. Rorsman, S. E. Jacobsen. 2006. Failure of transplanted bone marrow cells to adopt a pancreatic beta-cell fate. Diabetes. 55: 290-6 Timper, K., D. Seboek, M. Eberhardt., P. Linscheid, C. C. Mirjam, U. Keller, M. Beat, and H. Zulewski, 2006. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. BBRC. 341: 1135-1140. Todd, J. A., H. Acha-Orbea, J. I. Beell, N. Chao, Z. Fronek, C. O. Jacohb, M. McDeermott, A. A. Shinha, S. L. Timmerman, H. O. McDevitt. 1988. A molecular basis for MHC class 11-associated autolmmunity. Science 240: 1003-1009. Toth, E., A. Racz, J. Toth, P. M. Kaminski, M. S. Wolin, Z. Bagi, A. Koller. 2007. Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation. Am. J. Physiol. Heart Circ. Physiol.:293(5): H3096-104 Trevisan, R., G. C. Viberti. Pathophysiology of diabetic nephropathy. In: LeRoith D, Taylor SI, Olefsky JM.(eds). 2000. Diabetes Mellitus: A fundamental and Clinical Text. 898-910. Trimaratos, M., F. Roger, D. Chabardes, D. Mordasini, U. Hasler, A. Doucet, P. Y. Martin, E. Feraille. 2003. C-peptide stimulates Na-K ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46: 124-131. Mutskov, V., Bruce, M. R., Gary, F., Marvin, C., G. 2007. The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression. Stem cell. 25: 3223-3233 Wahren, J., K. Ekberg, H. Jornvall. 2007. C-peptide is a bioactive peptide. Diabetologia 50: 503-509. Wasikowa, R., A. Noczynska, A. Basiak. 2004. Transplantation in diabetes type 1--current problems and perspectives. Endokrynol Diabetol Chor. Przemiany Materii. Wieku. Rozw. 10: 119-22. Wakitani, S., T. Saito, A. I. Caplan. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 18: 1417-1426. Weir, G. C. 2004. Can we make surrogate beta-cells better than the original? Semin Cell Dev. Biol. 15: 347-57. Williams, A. J., R. J. Aitken, M. A. Chandler, K. M. Gillespie, V. Lampasona, Bingley PJ. 2008. Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia. 10: 1044-1047 Wu, K. I., Gannon, M. Peshavaria, M. F. Offield, E. Henderson, M. Ray. 1997. Hepatocyte nuclear factor 3 beta is involved in pancreatic beta cell specific transcription of the pdx-1 gene. Mol. cell Biol. 10: 6002-6013. Xu, J., M.Y. Zhu, Y. H. Lu, Y. Lu, Z. W. Wang. 2007. [Treatment of type 1 diabetes by transplantation of bone-derived mesenchymal stem cells expressing human insulin gene: experiment with mice]. Zhonghua Yi. Xue. Za. Zhi. 87: 2557-2560. Xu, X., J. D. Hoker, G. Stange, S. Bonne, N. De Leu, X. Xiao, M. Vande-Casteele, G. Mellitzer, Z. Ling, D. Pipeleers, L. Bouwens, R. Scharfmann, G. Gradwohl, and H. Heimberg. 2008. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132: 197-207. Yang, L., S. Li, H. Hatch, K. Ahrens, J. G. Cornelius, B. E. Petersen., A. B. Peck. 2002. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. U S A 99: 8078–8083 Zalzman, M., S. Gupta, R. K. Giri, I. Berkovich, B. S. Sappal, O. Karnieli, M. A. Zern, N. Fleischer, S. Efrat. 2003. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc. Nat.l Acad. Sci. U S A 100: 7253–7258. Zhang, W., H. Kamiya, K. Ekberg, J. Wahren, A. A. F. Sima. 2007. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. Diabetes Metab. Res. Rev. 23: 63-70. Zhong W, W. Chia. Neurogenesis and asymmetric cell division. 2008. Curr. Opin. Neurobiol. 10: 1016 Zimmet, P., M. Alberti, J. Shaw. 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782-787. Zorina, T. D., V. M. Subbotin, S. Bertera, A. M. Alexander, C. Haluszczak, B. Gambrell, R. Bottino, A. J. Styche, M. Trucco. 2003. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 21: 377–388. Zulewski, H. 2007. Stem cells with potential to generate insulin-producing cells in man. Swiss. Med. Wkly. 137 Suppl. 155: 60S-67S. Zulewski, H. 2008. Differentiation of embryonic and adult stem cells into insulin producing cells. Panminerva Med. 50: 73-9. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26417 | - |
dc.description.abstract | 第一型糖尿病為自體免疫缺失性疾病,導致病患胰臟之 β 細胞逐漸被自體抗體攻擊殆盡而導致高血糖,因而終生需仰賴外源胰島素治療。迄今,一般認為胰島細胞移植乃最符合生理之療法,但需面對胰島細胞來源缺乏與異體移植可能導致之免疫排斥問題,因此如何解決胰島細胞來源與免疫排斥,即成為當今研究需克服之目標。近期之研究證實骨髓間葉幹細胞 (mesenchymal stem cells, MSCs)可於體外成功轉分化為胰島細胞,體外分化約需 4 個月,且僅 10% 之分化率,效率仍低。曾有文獻指出細胞外基質 (extracellular matrix, ECM) 可促使細胞具有較好之遷移 (migrate) 及形成三級結構 (three-dimensional structure) 之能力,鑑此,如何利用細胞外基質與分化前之細胞結構單一細胞或團塊 (single cell or clumps),建立有利於提高 MSCs 分化為胰島素分泌細胞 (insulin producing cells, IPCs) 之效率,已成為本研究之重點目標。
本研究使用之螢光小鼠與豬之骨髓間葉幹細胞 (EGFP-mMSCs/EGFP-pMSCs)乃分離自攜帶 β-actin 啟動子之綠色螢光蛋白質 (enhanced green fluorescent protein, EGFP) 轉基因小鼠與豬之骨髓液。初期,本試驗利用不同濃度之葡萄糖 (17.5, 23.0, 28.5, 33, 39.5 mM) 添加於分化培養基中,擬建立 EGFP-pMSCs 與 EGFP-mMSCs 分化為 EGFP-pIPCs 與EGFP-mIPCs之誘導分化培養基。結果顯示 EGFP-pMSCs 於含 28.5 mM 葡萄糖誘導培養基誘導培養 18 天後,可獲得最佳之 EGFP-pIPCs 分化效率 (0.25 cluster/cm2),(P<0.01)。另於EGFP-mMSCs的分化誘導試驗中利用28.5 mM葡萄糖誘導培養 EGFP-mMSCs 18 天後亦得到較多之 EGFP-mIPCs (0.14 cluster/cm2),(P<0.01)。此外,本試驗利用不同分子量 (A組: MW > 120000, B組: MW > 300000, C組: MW > 500000) 之 poly-D-lysine 作為 ECM ,以磷酸緩衝液為控制組,探討其對於 EGFP-pMSCs 分化效率之影響。結果顯示 B 組於誘導 18 天後所得之 EGFP-pIPCs 分化效率較其他組別為高 (5.56 clusters/cm2)(P<0.05)。本試驗亦探討 MSCs 之細胞結構對於 EGFP-mMSCs 與 EGFP-pMSCs 分化為 EGFP-mIPCs/EGFP-pIPCs 之影響,本試驗以 EGFP-mMSCs 與 EGFP-pMSCs 為單細胞組 (single cells) 或細胞團 (clumps) 之細胞結構培養,結果顯示以細胞團結構之EGFP-mMSCs誘導5天後即可分化至 EGFP-mIPCs,而細胞團細胞結構之 EGFP-pMSCs 於誘導 9 天後亦可較獲得較多 (6.54 clusters/cm2) 之EGFP-pIPCs,(P<0.05),顯示立體細胞團塊之 MSCs 相較於單細胞組具有較高之 IPCs 分化效率。 對於分化後 EGFP-pIPCs 之分子特徵則以逆轉錄聚合酶連鎖反應技術分析之,針對胰臟特異性表現基因與轉錄因子包括:Insulin, Glucagon, Somatostatin, Glucokinase, Pax6, Nkx6.1, Glut2 等進行檢測,結果證實 EGFP-pIPCs 皆可表現前述基因。另進行即時定量聚合酶連鎖反應 (Real-Time PCR) 分析亦顯示 Insulin, Islet1, Nkx6.1, Glut2 基因表現量隨 EGFP-pMSCs 之分化天數 (第0天、第3天、第6天) 而逐漸增加。藉由細胞免疫染色技術亦證實分化後之 EGFP-mIPCs 與EGFP-pIPCs 皆可表現 Insulin 與 C-peptide 蛋白質。而 EGFP-pIPCs 亦於高糖 (28.5 mM) 之誘導下,於培養基中偵測到分泌之豬胰島素蛋白質,分泌濃度約 8.94±0.9 ng/ml。最後,以 PBS (200 μl)、EGFP-pMSCs (6╳106)、分化後之 EGFP-pIPCs (6╳106) 移植於 NOD/LtJ 第一型糖尿病小鼠皮下,結果顯示接受 EGFP-pIPCs 移植之 NOD/LtJ 小鼠血糖值下降幅度顯著高於其他組 (6╳106 MSCs, PBS, control),且 20 天內之存活率為 100%,他組則於 16 至 18 天死亡。 由以上結果顯示葡萄糖、細胞外基質與立體 MSCs 結構皆對於綠色螢光小鼠與豬之骨髓間葉幹細胞轉分化 (trans-differentiation) 為胰島素分泌細胞具有貢獻,並能改善其分化效率。再者,分化後之螢光豬胰島素分泌細胞經證實可分泌胰島素且異種移植至 NOD/LtJ 糖尿病小鼠皮下亦可降低其體內之高血糖。綜合上述,帶有螢光基因之骨髓間葉幹細胞可有效率的轉分化為胰島素分泌細胞,未來可進一步應用至大型糖尿病動物模式或人類臨床治療研究。 | zh_TW |
dc.description.abstract | Type I diabetes is an autoimmune disorder characterized by the progressing destructively loss of pancreatic β- cell. Efforts toward routine islet cell transplantation as a means for reversing type I diabetes have been hampered by islet availability as well as allograft rejection. Several studies have confirmed mesenchymal stem cells (MSCs) could trans-differentiate into insulin producing cells (IPCs), however, it took a long period (4 months) at a low frequency (10%). It was also reported that cells migration in three-dimensional extra-cellular matrix (ECM) plays a key role of cluster formation. Therefore, using ECM and cell mass structure to generate an ameliorated protocol for preparing a renewable and abundant transplantable islet clusters is demanded.
Marrow-derived MSCs isolating from the femur of transgenic porcine and mice (EGFP-pMSCs/EGFP-mMSCs) harboring with β-actin-EGFP (enhanced green fluorescent protein) gene were used in the studies. The first experiment, to generate an appropriate induction conditions that EGFP-pMSCs and EGFP-mMSCs differentiate into islet cells, different concentration (17.5, 23.0, 28.5, 33, 39.5 mM) glucose was added to induction medium to determine the effect of dose dependent. The result shows EGFP-pMSCs inducted with 28.5 mM glucose for 18 days, the formation ratio of islet-like cluster (0.25 cluster/cm2) is extremely higher than other groups (P<0.01). In the result of EGFP-mMSCs inducted to islet-like cluster (0.14 cluster/cm2) is similar to the tendency of EGFP-pMSCs induction by using 33 mM glucose. The second experiment, poly-D-lysine with three different molecular weight (MW) (MW > 120,000, MW > 300,000, MW > 500,000) were allocated to treatment groups (A, B and C) as ECM, respectively. The results indicated that islet-like cluster formation ratio (5.56 clusters/cm2) of IPCs in group B was significantly higher than other treated groups (P<0.05). Furthermore, EGFP-mMSCs/pMSCs with colonies and single cells were simultaneously seeded and cultured in induction medium to determine whether three-dimensional structures would effect IPCs induction. Experimental results revealed EGFP-mMSCs/pMSCs seeded by colonies exhibiting the largest number of IPCs (6.54 clusters/cm2) within 9 days (P<0.05), clarified the importance of colony formation. In addition, multiple genes include: Insulin, Glucagon, Somatostatin, Glucokinase, Pax6, Nkx6.1, Glut2, expression on inducted islet-like cells were determined by RT-PCR assay. Genes (Insulin, Islet1, Nkx6.1, Glut2) expression profile of time dependent (day0、day3、day6) were determined by Real-Time PCR. Immunocytochemistry was also used to confirm that EGFP-mIPCs/pIPCs are able to synthesize C-peptide and insulin. Insulin secretion level (8.94±0.9 ng/ml) in high glucose (28.5 mM) conditioned medium was quantitated by EIA. Further study regarding the hyperglycemia in NOD (non-obesity diabetes) mice were alleviated significantly after subcutaneous xenograft of 6×106 EGFP-pIPCs and the survival rate of transplanted mice within 20 days was 100%, but NOD mice treated with PBS, EGFP-pMSCs and control group survive up to 18 day. According to above results indicate glucose concentration containing in induction medium and ECM play a key role of cluster formation in EGFP-mMSCs/pMSCs induction, and improve their efficiency trans-differentiating into functional islet cell clusters even secret insulin to reverse the hyperglycemia of NOD mice via subcutaneous xenograft of EGFP-pIPCs. These observations propose that MSCs expressing GFP is capable of trans-differentiating into functional insulin-producing cells and is possible to extend to the studies of pig models of humans diabetes as a reference means to alleviate limitations of surrounding islet cell transplantation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T07:09:31Z (GMT). No. of bitstreams: 1 ntu-97-R95626011-1.pdf: 24148659 bytes, checksum: 9105e432ad1378982bd36450f0dde01a (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 口試委員會審定書…………………………………………………………………........I
致謝……………………………………………………………………………………...II 目錄…………………………………………………………………………………….III 圖次…………………………………………………………………………………….VI 表次…………………………………………………………………………………….XI 中文摘要……………………………………………………………………………....XII 英文摘要……………………………………………………………………………..XIV 第壹章 緒論………………………………………………………………….…………1 第貳章 文獻檢討 2.1 糖尿病 2.1.1 第一型糖尿病…………………………………………………………...5 2.2 Insulin與C-peptide之生物合成 2.2.1 胰島素之化學結構…………...…………………………….…………...7 2.2.2 胰島素之生物合成…………..…….....................................……….…...8 2.2.3 C-peptide於糖尿病併發症之影響………………………………...…...10 2.3 幹細胞 2.3.1 幹細胞…………..………………………………………………...11 2.3.2 間葉幹細胞……………………………………………………….13 2.4 應用幹細胞治療糖尿病之研究………………………………………..........14 2.5 胰島細胞移植之研究進展….……………………………………………….17 第参章 試驗研究 試驗一 綠色螢光小鼠與豬骨髓間葉幹細胞之分離與純化 (一) 前言………………………………………………………………………….21 (二) 材料與方法……………………………………………………………….....22 (三) 結果……….……………………………………………………….………...27 (四) 討論……………….……………………………………………….………...31 (五) 結論……………….……………………………………………….………...32 試驗二 葡萄糖對於綠色螢光小鼠與豬之骨髓間葉幹細胞轉分化為胰島細胞之 影響 (一) 前言…………………………………………………………………………33 (二) 材料與方法…………………………………………………………………36 (三) 結果…………………………………………………………….…...............39 (四) 討論…………………………………………………………….…...............52 (五) 結論…………………………………………………………………………55 試驗三 細胞外基質對於綠色螢光小鼠與豬之骨髓間葉幹細胞轉分化為胰 島細胞之影響 (一) 前言…………………………………………………………………………56 (二) 材料與方法…………………………………………………………………59 (三) 結果…………………………………………………………….…...............63 (四) 討論…………………………………………………………….…...............70 (五) 結論…………………………………………………………………………73 試驗四 Clumps/colonies三級結構對於綠色螢光小鼠與豬骨髓間葉幹細胞轉分化為胰島細胞之影響 (一) 前言…………………………………………………………………………74 (二) 材料與方法…………………………………………………………………76 (三) 結果…………………………………………………………….…...............88 (四) 討論…………………………………………………………….…..............109 (五) 結論………………………………………………………………………...113 試驗五 源自綠色螢光豬MSCs誘導轉分化胰島素分泌細胞經移植於NOD/LtJ 糖尿病小鼠之皮下治療 (一) 前言………………………………………………………………………...114 (二) 材料與方法….……………………………………………………………..115 (三) 結果………….……………………………………………………………..120 (四) 討論………….………………………………………………….….............125 (五) 結論………………………………………………………………………...127 第肆章 總結………………………………………………………………………….128 第伍章 未來展望…………………………………………………………………….130 第陸章 參考文獻……………………………………………………………….…....133 第柒章 作者小傳………………………………………………………..…………...146 第捌章 附錄………………………………………………………………………….147 | |
dc.language.iso | zh-TW | |
dc.title | 綠色螢光小鼠與豬之骨髓間葉幹細胞轉分化成胰島素分泌細胞之研究 | zh_TW |
dc.title | Trans-differentiation of Bone Marrow-derived EGFP-mMSCs and EGFP-pMSCs into Insulin-Producing Cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄭登貴,黃效民,黃木秋,陳全木 | |
dc.subject.keyword | 糖尿病,胰島素分泌細胞,幹細胞, | zh_TW |
dc.subject.keyword | diabetes,insulin producing cells,stem cells, | en |
dc.relation.page | 147 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2008-08-01 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 23.58 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。